{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T06:41:42Z","timestamp":1740120102769,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T00:00:00Z","timestamp":1649116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81671936"],"award-info":[{"award-number":["81671936"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s12185-022-03337-5","type":"journal-article","created":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:08:35Z","timestamp":1649153315000},"page":"48-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Phenotype-oriented anticoagulant therapy for sepsis: still a work in progress"],"prefix":"10.1007","volume":"116","author":[{"given":"Sihan","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5255-3534","authenticated-orcid":false,"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,4,5]]},"reference":[{"key":"3337_CR1","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","volume":"149","author":"M Levi","year":"2017","unstructured":"Levi M, van der Poll T. Coagulation and sepsis. Thromb Res. 2017;149:38\u201344.","journal-title":"Thromb Res"},{"issue":"3","key":"3337_CR2","doi-asserted-by":"publisher","first-page":"R111","DOI":"10.1186\/cc12783","volume":"17","author":"S Gando","year":"2013","unstructured":"Gando S, Saitoh D, Ogura H, Fujishima S, Mayumi T, Araki T, et al. A multicenter, prospective validation study of the Japanese association for acute medicine disseminated intravascular coagulation scoring system in patients with severe sepsis. Crit Care. 2013;17(3):R111.","journal-title":"Crit Care"},{"key":"3337_CR3","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.thromres.2019.04.025","volume":"178","author":"S Gando","year":"2019","unstructured":"Gando S, Shiraishi A, Yamakawa K, Ogura H, Saitoh D, Fujishima S, et al. Role of disseminated intravascular coagulation in severe sepsis. Thromb Res. 2019;178:182\u20138.","journal-title":"Thromb Res"},{"issue":"3","key":"3337_CR4","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","volume":"43","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016. Intensive Care Med. 2017;43(3):304\u201377.","journal-title":"Intensive Care Med"},{"key":"3337_CR5","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/CCM.0b013e3181c9e31d","volume":"38","author":"S Gando","year":"2010","unstructured":"Gando S. Microvascular thrombosis and multiple organ dysfunction syndrome. Crit Care Med. 2010;38:S35-42.","journal-title":"Crit Care Med"},{"key":"3337_CR6","doi-asserted-by":"publisher","first-page":"16037","DOI":"10.1038\/nrdp.2016.37","volume":"2","author":"S Gando","year":"2016","unstructured":"Gando S, Levi M, Toh CH. Disseminated intravascular coagulation. Nat Rev Dis Primers. 2016;2:16037.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"3337_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s40560-021-00555-7","volume":"9","author":"M Egi","year":"2021","unstructured":"Egi M, Ogura H, Yatabe T, Atagi K, Inoue S, Iba T, et al. The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2020 (J-SSCG 2020). J Intensive Care. 2021;9(1):53.","journal-title":"J Intensive Care"},{"issue":"3","key":"3337_CR8","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1172\/JCI109521","volume":"64","author":"W Kisiel","year":"1979","unstructured":"Kisiel W. Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest. 1979;64(3):761\u20139.","journal-title":"J Clin Invest"},{"issue":"2","key":"3337_CR9","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1515\/bchm2.1981.362.1.103","volume":"362","author":"M Jochum","year":"1981","unstructured":"Jochum M, Lander S, Heimburger N, Fritz H. Effect of human granulocytic elastase on isolated human antithrombin III. Hoppe Seylers Z Physiol Chem. 1981;362(2):103\u201312.","journal-title":"Hoppe Seylers Z Physiol Chem"},{"issue":"3","key":"3337_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/SHK.0b013e3182236e7e","volume":"36","author":"FY Lin","year":"2011","unstructured":"Lin FY, Tsai YT, Lee CY, Lin CY, Lin YW, Li CY, et al. TNF-\u03b1-decreased thrombomodulin expression in monocytes is inhibited by propofol through regulation of tristetraprolin and human antigen R activities. Shock. 2011;36(3):279\u201388.","journal-title":"Shock"},{"issue":"6","key":"3337_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1055\/s-2001-18867","volume":"27","author":"CE Hack","year":"2001","unstructured":"Hack CE. Fibrinolysis in disseminated intravascular coagulation. Semin Thromb Hemost. 2001;27(6):633\u20138.","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"3337_CR12","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1097\/00003246-200107001-00028","volume":"29","author":"M Levi","year":"2001","unstructured":"Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Crit Care Med. 2001;29(7):S90\u20134.","journal-title":"Crit Care Med"},{"issue":"13","key":"3337_CR13","doi-asserted-by":"publisher","first-page":"17220","DOI":"10.18632\/oncotarget.7948","volume":"7","author":"H Peng","year":"2016","unstructured":"Peng H, Zhang Q, Li J, Zhang N, Hua Y, Xu L, et al. Apatinib inhibits VEGF signaling and promotes apoptosis in intrahepatic cholangiocarcinoma. Oncotarget. 2016;7(13):17220\u20139.","journal-title":"Oncotarget"},{"issue":"9","key":"3337_CR14","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1097\/CCM.0b013e318258ff30","volume":"40","author":"F Fourrier","year":"2012","unstructured":"Fourrier F. Severe sepsis, coagulation, and fibrinolysis: dead end or one way? Crit Care Med. 2012;40(9):2704\u20138.","journal-title":"Crit Care Med"},{"issue":"9","key":"3337_CR15","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","volume":"41","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N, et al. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med. 2013;41(9):2069\u201379.","journal-title":"Crit Care Med"},{"issue":"1","key":"3337_CR16","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s13054-016-1415-1","volume":"20","author":"K Yamakawa","year":"2016","unstructured":"Yamakawa K, Umemura Y, Hayakawa M, et al. Benefit profile of anticoagulant therapy in sepsis: a nationwide multicentre registry in Japan. Crit Care. 2016;20(1):229.","journal-title":"Crit Care"},{"issue":"3","key":"3337_CR17","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/jth.13230","volume":"14","author":"Y Umemura","year":"2016","unstructured":"Umemura Y, Yamakawa K, Ogura H, Yuhara H, Fujimi S. Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials. J Thromb Haemost. 2016;14(3):518\u201330.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"3337_CR18","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/jth.13946","volume":"16","author":"Y Umemura","year":"2018","unstructured":"Umemura Y, Yamakawa K. Optimal patient selection for anticoagulant therapy in sepsis: an evidence-based proposal from Japan. J Thromb Haemost. 2018;16(3):462\u20134.","journal-title":"J Thromb Haemost"},{"issue":"20","key":"3337_CR19","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1001\/jama.2019.5358","volume":"321","author":"JL Vincent","year":"2019","unstructured":"Vincent JL, Francois B, Zabolotskikh I, Daga MK, Lascarrou JB, Kirov MY, et al. Effect of a recombinant human soluble thrombomodulin on mortality in patients with sepsis-associated coagulopathy: The SCARLET randomized clinical trial. JAMA. 2019;321(20):1993\u20132002.","journal-title":"JAMA"},{"issue":"1","key":"3337_CR20","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1055\/s-0038-1676345","volume":"119","author":"K Yamakawa","year":"2019","unstructured":"Yamakawa K, Murao S, Aihara M. Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and meta-analysis. Thromb Haemost. 2019;119(1):56\u201365.","journal-title":"Thromb Haemost"},{"issue":"7","key":"3337_CR21","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1111\/jth.14812","volume":"18","author":"E Valeriani","year":"2020","unstructured":"Valeriani E, Squizzato A, Gallo A, Porreca E, Vincent JL, Iba T, et al. Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis. J Thromb Haemost. 2020;18(7):1618\u201325.","journal-title":"J Thromb Haemost"},{"issue":"20","key":"3337_CR22","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.2019.5791","volume":"321","author":"CW Seymour","year":"2019","unstructured":"Seymour CW, Kennedy JN, Wang S, Chang CCH, Elliott CF, Xu Z, et al. Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 2019;321(20):2003\u201317.","journal-title":"JAMA"},{"issue":"1","key":"3337_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s13054-018-2279-3","volume":"22","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Zhang G, Goyal H, Mo L, Hong Y. Identification of subclasses of sepsis that showed different clinical outcomes and responses to amount of fluid resuscitation: a latent profile analysis. Crit Care. 2018;22(1):347.","journal-title":"Crit Care"},{"issue":"1","key":"3337_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13054-021-03541-5","volume":"25","author":"D Kudo","year":"2021","unstructured":"Kudo D, Goto T, Uchimido R, Hayakawa M, Yamakawa K, Abe T, et al. Coagulation phenotypes in sepsis and effects of recombinant human thrombomodulin: an analysis of three multicentre observational studies. Crit Care. 2021;25(1):114.","journal-title":"Crit Care"},{"issue":"9","key":"3337_CR25","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017046","volume":"7","author":"T Iba","year":"2017","unstructured":"Iba T, Nisio MD, Levy JH, Kitamura N, Thachil J. New criteria for sepsis-induced coagulopathy (SIC) following the revised sepsis definition: a retrospective analysis of a nationwide survey. BMJ Open. 2017;7(9): e017046.","journal-title":"BMJ Open"},{"issue":"3","key":"3337_CR26","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.thromres.2011.10.013","volume":"129","author":"N Semeraro","year":"2012","unstructured":"Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res. 2012;129(3):290\u20135.","journal-title":"Thromb Res"},{"issue":"1","key":"3337_CR27","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1055\/s-0037-1617143","volume":"30","author":"M Levi","year":"2010","unstructured":"Levi M. The coagulant response in sepsis and inflammation. Hamostaseologie. 2010;30(1):10\u20132.","journal-title":"Hamostaseologie"},{"issue":"2","key":"3337_CR28","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5492\/wjccm.v4.i2.105","volume":"4","author":"KS Allen","year":"2015","unstructured":"Allen KS, Sawheny E, Kinasewitz GT. Anticoagulant modulation of inflammation in severe sepsis. World J Crit Care Med. 2015;4(2):105\u201315.","journal-title":"World J Crit Care Med"},{"issue":"10","key":"3337_CR29","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1097\/01.CCM.0000282072.56245.91","volume":"35","author":"E Abraham","year":"2007","unstructured":"Abraham E, Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med. 2007;35(10):2408\u201316.","journal-title":"Crit Care Med"},{"issue":"4","key":"3337_CR30","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/SHK.0000000000000221","volume":"42","author":"G Camicia","year":"2014","unstructured":"Camicia G, Pozner R, de Larra\u00f1aga G. Neutrophil extracellular traps in sepsis. Shock. 2014;42(4):286\u201394.","journal-title":"Shock"},{"issue":"2","key":"3337_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1055\/s-0038-1676610","volume":"119","author":"K Yamakawa","year":"2019","unstructured":"Yamakawa K, Yoshimura J, Ito T, Hayakawa M, Hamasaki T, Fujimi S. External validation of the two newly proposed criteria for assessing coagulopathy in sepsis. Thromb Haemost. 2019;119(2):203\u201312.","journal-title":"Thromb Haemost"},{"issue":"7","key":"3337_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0885066618773679","volume":"35","author":"T Iba","year":"2020","unstructured":"Iba T, Arakawa M, Di Nisio M, Gando S, Anan H, Sato K, et al. Newly proposed sepsis-induced coagulopathy precedes international society on thrombosis and haemostasis overt-disseminated intravascular coagulation and predicts high mortality. J Intensive Care Med. 2020;35(7):643\u20139.","journal-title":"J Intensive Care Med"},{"issue":"2","key":"3337_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/jth.14354","volume":"17","author":"T Iba","year":"2019","unstructured":"Iba T, Levy JH, Wada H, Thachil J, Warkentin TE, Levi M. Differential diagnoses for sepsis-induced disseminated intravascular coagulation: communication from the SSC of the ISTH. J Thromb Haemost. 2019;17(2):415\u20139.","journal-title":"J Thromb Haemost"},{"key":"3337_CR34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","volume":"34","author":"K Oikonomopoulou","year":"2012","unstructured":"Oikonomopoulou K, Ricklin D, Ward PA, et al. Interactions between coagulation and complement\u2013their role in inflammation. Semin Immunopathol. 2012;34:151\u201365.","journal-title":"Semin Immunopathol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-022-03337-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-022-03337-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T17:01:55Z","timestamp":1656003715000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-022-03337-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,5]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["3337"],"URL":"https:\/\/doi.org\/10.1007\/s12185-022-03337-5","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"type":"print","value":"0925-5710"},{"type":"electronic","value":"1865-3774"}],"subject":[],"published":{"date-parts":[[2022,4,5]]},"assertion":[{"value":"31 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}